Taro to Announce Second Quarter Results on November 7, 2017
October 30 2017 - 5:01PM
Business Wire
Earnings Call to Discuss Results to be
Conducted Wednesday, November 8 at 8:00 am ET
Taro Pharmaceutical Industries Ltd. (NYSE:TARO) ("TARO" or the
"Company") announced today that it plans to release its financial
results for the quarter and six months ended September 30, 2017, on
Tuesday, November 7, 2017.
The Company will conduct an earnings call at 8:00 am EST on
Wednesday, November 8, 2017, where senior management will discuss
the Company’s performance and answer questions from
participants.
The release will be accessible on Taro’s website at
www.taro.com.
Earnings Call (8:00 am EST
on Wednesday, November 8, 2017)
To participate in this conference call, please dial the numbers
provided below five to ten minutes ahead of the scheduled start
time. The operator will provide instructions on asking questions
before the call. You can also hear the call via an audio webcast,
details of which will be announced later on the Company website,
www.taro.com. A transcript of this earnings call will also be
available on the website.
Summary of events
Event Date and time Telephone number/
website Earnings release November 7, 2017 (AMC)
www.taro.com
Earnings conference call
8:00 am EST
November 8, 2017
Participant Toll-Free Dial-In Number: +1
(844) 421-0601
Participant International Dial-In Number:
+1 (716) 247-5800
ID: 4298818
Via audio webcast, details of which will
be made available on www.taro.com
Replay of conference call November 8, 2017 to
November 30, 2017
+ 1 (855) 859-2056 or +1 (404)
537-3406
ID: 4298818
Via audio webcast playback, details of
which will be made available on www.taro.com
About Taro
Taro Pharmaceutical Industries Ltd. is a multinational,
science-based pharmaceutical company, dedicated to meeting the
needs of its customers through the discovery, development,
manufacturing and marketing of the highest quality healthcare
products. For further information on Taro Pharmaceutical Industries
Ltd., please visit the Company’s website at www.taro.com.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20171030006235/en/
Taro Pharmaceutical Industries Ltd.Mariano A. BalaguerVP,
CFO914-345-9001Mariano.Balaguer@taro.comWilliam J. CooteAVP,
Business Finance, Treasurer and Investor
Relations914-345-9001William.Coote@taro.com
Taro Pharmaceutical Indu... (NYSE:TARO)
Historical Stock Chart
From Aug 2024 to Sep 2024
Taro Pharmaceutical Indu... (NYSE:TARO)
Historical Stock Chart
From Sep 2023 to Sep 2024